{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,7]],"date-time":"2026-01-07T14:42:22Z","timestamp":1767796942808,"version":"3.49.0"},"reference-count":48,"publisher":"BMJ","issue":"12","license":[{"start":{"date-parts":[[2025,12,18]],"date-time":"2025-12-18T00:00:00Z","timestamp":1766016000000},"content-version":"unspecified","delay-in-days":17,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Open"],"accepted":{"date-parts":[[2025,12,5]]},"published-print":{"date-parts":[[2025,12]]},"abstract":"\n Objectives<\/jats:title>\n This study aimed to examine the association between the neutrophil-to-lymphocyte ratio (NLR) and the prognosis of patients with breast cancer (BC) in southern Ethiopia.<\/jats:p>\n <\/jats:sec>\n \n Design<\/jats:title>\n We conducted a hospital-based retrospective cohort study.<\/jats:p>\n <\/jats:sec>\n \n Setting<\/jats:title>\n The study was conducted at Hawassa and Wolaita Sodo University Comprehensive Specialized Hospital.<\/jats:p>\n <\/jats:sec>\n \n Participants<\/jats:title>\n A total of 492\u2009women with BC diagnosed from January 2020 to December 2022 were enrolled. Follow-up extended from the date of diagnosis until the occurrence of an event (death), loss to follow-up or the study end date.<\/jats:p>\n <\/jats:sec>\n \n Outcome measures<\/jats:title>\n Data were collected using a structured data collection tool through medical record review and exported to Stata V.16 for analysis. Unweighted and weighted Kaplan-Meier survival curves were used to estimate death-free survival time. Inverse-probability-weighted regression adjustment was employed to estimate the association of NLR with time to death. At a statistical significance level of p<0.05, regression coefficients with 95% CIs were reported.<\/jats:p>\n <\/jats:sec>\n \n Results<\/jats:title>\n The incidence of mortality in patients with BC with a higher NLR was 4.2 (95% CI 3.3 to 5.2) per 100 person-month observation (PMO); it was 1.9 (95% CI 1.5 to 2.4) per 100 PMO for those with a low NLR. When everyone in the population of interest has a low NLR, the average time to death is estimated as 17.2 (95% CI 11.4 to 23.0) months. For women with a higher NLR, the average time to death is estimated as 10.8 (95% CI 8.93 to 12.8) months. For women with a higher NLR, the average time to death was shorter by 6.3 months (coefficient: \u22126.3, 95%\u2009CI \u221212.5 to \u20130.082). Furthermore, the effectiveness of exposure to high NLR (ratio of average treatment effect to low NLR potential outcome means) was a 36.7% (95% CI 12% to 61%) reduction in mortality rate.<\/jats:p>\n <\/jats:sec>\n \n Conclusions<\/jats:title>\n A high NLR was associated with significantly higher mortality in BC patients, independent of baseline clinicopathological variables. Patients with elevated NLR more often presented with advanced stage disease and distant metastases. These findings indicate that NLR, a simple and accessible biomarker, may help to identify patients at increased risk of poor prognosis.<\/jats:p>\n <\/jats:sec>","DOI":"10.1136\/bmjopen-2025-102933","type":"journal-article","created":{"date-parts":[[2025,12,18]],"date-time":"2025-12-18T10:50:28Z","timestamp":1766055028000},"page":"e102933","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":0,"title":["Prognostic value of neutrophil-to-lymphocyte ratio in patients with breast cancer in Ethiopia: using inverse-probability-weighted regression adjustment"],"prefix":"10.1136","volume":"15","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2006-6368","authenticated-orcid":false,"given":"Desalegn Dawit","family":"Assele","sequence":"first","affiliation":[{"name":"Department of Public Health, Hawassa University, Hawassa, Ethiopia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bitsiet","family":"Desta","sequence":"additional","affiliation":[{"name":"Department of Nursing, Wolaita Sodo University, Wolaita Sodo, Ethiopia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tinbite","family":"Esayas","sequence":"additional","affiliation":[{"name":"Department of Surgery, Hawassa University College of Medicine and Health Sciences, Hawassa, Ethiopia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5567-0894","authenticated-orcid":false,"given":"Tadele Dana","family":"Darebo","sequence":"additional","affiliation":[{"name":"School of Public Health, Wolaita Sodo University, Wolaita Sodo, Ethiopia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Berhanetsehay","family":"Teklewold","sequence":"additional","affiliation":[{"name":"Department of Surgery, Saint Paul\u2019s Hospital Millenium Medical College, Addis Ababa, Ethiopia"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"239","published-online":{"date-parts":[[2025,12,18]]},"reference":[{"key":"2026010703473464000_15.12.e102933.1","unstructured":"WHO . Breast cancer fact sheet. 2021. Available: https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/breast-cancer"},{"key":"2026010703473464000_15.12.e102933.2","doi-asserted-by":"publisher","DOI":"10.1016\/j.breast.2022.08.010"},{"key":"2026010703473464000_15.12.e102933.3","doi-asserted-by":"publisher","DOI":"10.3322\/caac.21660"},{"key":"2026010703473464000_15.12.e102933.4","doi-asserted-by":"crossref","DOI":"10.1186\/s13027-017-0124-y","article-title":"An update on the management of breast cancer in Africa","volume":"12","author":"Vanderpuye","year":"2017","journal-title":"Infect Agents Cancer"},{"key":"2026010703473464000_15.12.e102933.5","doi-asserted-by":"crossref","first-page":"e1203","DOI":"10.1016\/S2214-109X(20)30261-8","article-title":"Breast cancer survival and survival gap apportionment in sub-Saharan Africa (ABC-DO): a prospective cohort study","volume":"8","author":"McCormack","year":"2020","journal-title":"Lancet Glob Health"},{"key":"2026010703473464000_15.12.e102933.6","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1200\/GO.20.00538","article-title":"Survival Outcomes of Breast Cancer in Sudanese Women: A Hospital-Based Study","volume":"7","author":"Muddather","year":"2021","journal-title":"JCO Glob Oncol"},{"key":"2026010703473464000_15.12.e102933.7","first-page":"393","article-title":"Outcomes and prognostic factors for women with breast cancer in Malawi","volume":"31","author":"Youngblood","year":"2020","journal-title":"Cancer Causes Control"},{"key":"2026010703473464000_15.12.e102933.8","doi-asserted-by":"publisher","DOI":"10.2147\/CMAR.S339988"},{"key":"2026010703473464000_15.12.e102933.9","doi-asserted-by":"crossref","unstructured":"Tesfay B , Getinet T , Derso EA . Survival analysis of Time to Death of Breast Cancer Patients: in case of Ayder Comprehensive Specialized Hospital Tigray, Ethiopia. Cogent Med 2021;8. doi:10.1080\/2331205X.2021.1908648","DOI":"10.1080\/2331205X.2021.1908648"},{"key":"2026010703473464000_15.12.e102933.10","doi-asserted-by":"crossref","first-page":"5567","DOI":"10.2147\/OTT.S108419","article-title":"The neutrophil lymphocyte ratio is associated with breast cancer prognosis: an updated systematic review and meta-analysis","volume":"9","author":"Wei","year":"2016","journal-title":"Onco Targets Ther"},{"key":"2026010703473464000_15.12.e102933.11","doi-asserted-by":"crossref","DOI":"10.1038\/s41392-021-00658-5","article-title":"Inflammation and tumor progression: signaling pathways and targeted intervention","volume":"6","author":"Zhao","year":"2021","journal-title":"Signal Transduct Target Ther"},{"key":"2026010703473464000_15.12.e102933.12","doi-asserted-by":"crossref","first-page":"S85","DOI":"10.4103\/0973-1482.160917","article-title":"Meta-analysis of prognostic value of inflammation parameter in breast cancer","volume":"14","author":"Chen","year":"2018","journal-title":"J Cancer Res Ther"},{"key":"2026010703473464000_15.12.e102933.13","doi-asserted-by":"publisher","DOI":"10.1016\/j.fob.2015.05.003"},{"key":"2026010703473464000_15.12.e102933.14","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000014126","article-title":"Prognostic significance of elevated preoperative neutrophil-to-lymphocyte ratio for patients with colorectal cancer undergoing curative surgery","volume":"98","author":"Li","year":"2019","journal-title":"Medicine (Baltimore)"},{"key":"2026010703473464000_15.12.e102933.15","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1002\/kjm2.12694","article-title":"Prognostic value of neutrophil-to-lymphocyte ratio in gastric cancer patients treated with immune checkpoint inhibitors: A meta-analysis","volume":"39","author":"Li","year":"2023","journal-title":"Kaohsiung J Med Sci"},{"key":"2026010703473464000_15.12.e102933.16","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1186\/s12935-023-02876-z","article-title":"The prognostic utility of preoperative neutrophil-to-lymphocyte ratio (NLR) in patients with colorectal liver metastasis: a systematic review and meta-analysis","volume":"23","author":"Li","year":"2023","journal-title":"Cancer Cell Int"},{"key":"2026010703473464000_15.12.e102933.17","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000029887","article-title":"Prognostic value of neutrophil-to-lymphocyte ratio for patients with triple-negative breast cancer: A meta-analysis","volume":"101","author":"Liu","year":"2022","journal-title":"Medicine (Baltimore)"},{"key":"2026010703473464000_15.12.e102933.18","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1111\/his.15125","article-title":"Neutrophil-lymphocyte ratio reflects tumour-infiltrating lymphocytes and tumour-associated macrophages and independently predicts poor outcome in breast cancers with neoadjuvant chemotherapy","volume":"84","author":"Li","year":"2024","journal-title":"Histopathology"},{"key":"2026010703473464000_15.12.e102933.19","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-023-50378-9","article-title":"Neutrophil-to-lymphocyte ratio is a prognostic factor reflecting immune condition of tumor microenvironment in squamous cell lung cancer","volume":"14","author":"Ohashi","year":"2024","journal-title":"Sci Rep"},{"key":"2026010703473464000_15.12.e102933.20","doi-asserted-by":"crossref","first-page":"721","DOI":"10.26719\/2017.23.11.721","article-title":"Prognostic Factors of Breast Cancer Survival in the Islamic Republic of Iran: an Additive Empirical Bayesian Approach","volume":"23","author":"Nematolahi","year":"2018","journal-title":"East Mediterr Health J"},{"key":"2026010703473464000_15.12.e102933.21","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-019-56218-z","article-title":"Exploring the prognostic value of the neutrophil-to-lymphocyte ratio in cancer","volume":"9","author":"Howard","year":"2019","journal-title":"Sci Rep"},{"key":"2026010703473464000_15.12.e102933.22","doi-asserted-by":"publisher","DOI":"10.1093\/ckj\/sfab158"},{"key":"2026010703473464000_15.12.e102933.23","doi-asserted-by":"publisher","DOI":"10.1093\/aje\/kwq439"},{"key":"2026010703473464000_15.12.e102933.24","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0282746","article-title":"Survival and predictors of breast cancer mortality in South Ethiopia: A retrospective cohort study","volume":"18","author":"Shita","year":"2023","journal-title":"PLoS One"},{"key":"2026010703473464000_15.12.e102933.25","article-title":"Optimal Cutoff for the Neutrophil-to-Lymphocyte Ratio as a Tool for Pre-chemotherapy Prognosis Stratification of Breast Cancer Patients","volume":"17","author":"Zandi","year":"2025","journal-title":"Cureus"},{"key":"2026010703473464000_15.12.e102933.26","doi-asserted-by":"crossref","DOI":"10.1186\/s12885-021-09112-9","article-title":"Neutrophil-to-lymphocyte ratio as a prognostic factor for patients with metastatic or recurrent breast cancer treated using capecitabine: a retrospective study","volume":"22","author":"Takamizawa","year":"2022","journal-title":"BMC Cancer"},{"key":"2026010703473464000_15.12.e102933.27","unstructured":"American Cancer Society . Breast cancer facts & figures 2017-2018. Atlanta American Cancer Society; 2017."},{"key":"2026010703473464000_15.12.e102933.28","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.28691"},{"key":"2026010703473464000_15.12.e102933.29","doi-asserted-by":"crossref","DOI":"10.1038\/srep05360","article-title":"Clinicopathological features and prognostic factors of young breast cancers in Eastern Guangdong of China","volume":"4","author":"Wei","year":"2014","journal-title":"Sci Rep"},{"key":"2026010703473464000_15.12.e102933.30","doi-asserted-by":"crossref","DOI":"10.1177\/11782234221108058","article-title":"Determining Prognostic Factors of Disease-Free Survival in Breast Cancer Using Censored Quantile Regression","volume":"16","author":"Yazdani","year":"2022","journal-title":"Breast Cancer (Auckl)"},{"key":"2026010703473464000_15.12.e102933.31","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1097-0258(19981015)17:19<2265::AID-SIM918>3.0.CO;2-B"},{"key":"2026010703473464000_15.12.e102933.32","doi-asserted-by":"publisher","DOI":"10.1016\/j.jclinepi.2013.01.013"},{"key":"2026010703473464000_15.12.e102933.33","doi-asserted-by":"publisher","DOI":"10.1002\/sim.2739"},{"key":"2026010703473464000_15.12.e102933.34","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0243447","article-title":"Neutrophil-to-lymphocyte ratio predicts early mortality in females with metastatic triple-negative breast cancer","volume":"15","author":"de la Cruz-Ku","year":"2020","journal-title":"PLoS One"},{"key":"2026010703473464000_15.12.e102933.35","doi-asserted-by":"crossref","first-page":"1065606","DOI":"10.3389\/fonc.2022.1065606","article-title":"The predictive value of neutrophil-to-lymphocyte ratio for overall survival and pathological complete response in breast cancer patients receiving neoadjuvant chemotherapy","volume":"12","author":"Gao","year":"2022","journal-title":"Front Oncol"},{"key":"2026010703473464000_15.12.e102933.36","doi-asserted-by":"crossref","DOI":"10.1186\/s12885-020-07700-9","article-title":"Dynamic changes of neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio predicts breast cancer prognosis","volume":"20","author":"Kim","year":"2020","journal-title":"BMC Cancer"},{"key":"2026010703473464000_15.12.e102933.37","doi-asserted-by":"publisher","DOI":"10.4048\/jbc.2013.16.1.55"},{"key":"2026010703473464000_15.12.e102933.38","first-page":"153","article-title":"The Effect of Estrogen Receptor Status on Survival in Breast Cancer Patients in Ethiopia. Retrospective Cohort Study","volume":"14","author":"Belete","year":"2022","journal-title":"Breast Cancer (Dove Med Press)"},{"key":"2026010703473464000_15.12.e102933.39","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1604700"},{"key":"2026010703473464000_15.12.e102933.40","doi-asserted-by":"crossref","DOI":"10.3390\/cancers13143472","article-title":"Time-Sequencing of the Neutrophil-to-Lymphocyte Ratio to Predict Prognosis of Triple-Negative Breast Cancer","volume":"13","author":"Kim","year":"2021","journal-title":"Cancers (Basel)"},{"key":"2026010703473464000_15.12.e102933.41","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0120832","article-title":"Survival after locoregional recurrence or second primary breast cancer: impact of the disease-free interval","volume":"10","author":"Witteveen","year":"2015","journal-title":"PLoS One"},{"key":"2026010703473464000_15.12.e102933.42","doi-asserted-by":"crossref","DOI":"10.1186\/s12885-016-2352-8","article-title":"Pretreatment neutrophil-to-lymphocyte ratio is correlated with response to neoadjuvant chemotherapy as an independent prognostic indicator in breast cancer patients: a retrospective study","volume":"16","author":"Chen","year":"2016","journal-title":"BMC Cancer"},{"key":"2026010703473464000_15.12.e102933.43","doi-asserted-by":"publisher","DOI":"10.1016\/j.clgc.2015.02.001"},{"key":"2026010703473464000_15.12.e102933.44","doi-asserted-by":"crossref","first-page":"2244","DOI":"10.3892\/ol.2015.3575","article-title":"Prediction of chemotherapeutic efficacy using the ratio of neutrophils to lymphocytes in patients with unresectable or recurrent gastric cancer","volume":"10","author":"Liu","year":"2015","journal-title":"Oncol Lett"},{"key":"2026010703473464000_15.12.e102933.45","doi-asserted-by":"crossref","DOI":"10.1186\/s13058-016-0794-1","article-title":"Prognostic role of neutrophil-to-lymphocyte ratio in breast cancer: a systematic review and meta-analysis","volume":"19","author":"Ethier","year":"2017","journal-title":"Breast Cancer Res"},{"key":"2026010703473464000_15.12.e102933.46","doi-asserted-by":"crossref","DOI":"10.1186\/1471-2407-5-48","article-title":"Minimum follow-up time required for the estimation of statistical cure of cancer patients: verification using data from 42 cancer sites in the SEER database","volume":"5","author":"Tai","year":"2005","journal-title":"BMC Cancer"},{"key":"2026010703473464000_15.12.e102933.47","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2013.50.7442"},{"key":"2026010703473464000_15.12.e102933.48","doi-asserted-by":"crossref","first-page":"1890","DOI":"10.1002\/ijc.34871","article-title":"Incidence of late recurrence and second primary cancers 5-10\u2009years after non-metastatic colorectal cancer","volume":"154","author":"Nors","year":"2024","journal-title":"Int J Cancer"}],"container-title":["BMJ Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bmjopen-2025-102933","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,7]],"date-time":"2026-01-07T11:49:55Z","timestamp":1767786595000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmjopen.bmj.com\/lookup\/doi\/10.1136\/bmjopen-2025-102933"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12]]},"references-count":48,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2025,12,18]]},"published-print":{"date-parts":[[2025,12]]}},"alternative-id":["10.1136\/bmjopen-2025-102933"],"URL":"https:\/\/doi.org\/10.1136\/bmjopen-2025-102933","relation":{},"ISSN":["2044-6055","2044-6055"],"issn-type":[{"value":"2044-6055","type":"print"},{"value":"2044-6055","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12]]}}}